IL257350A - 5-bromo-2,6-di-(lh-pyrazol-l-yl)pyrimidin-4-amine for use in the treatment of cancer - Google Patents

5-bromo-2,6-di-(lh-pyrazol-l-yl)pyrimidin-4-amine for use in the treatment of cancer

Info

Publication number
IL257350A
IL257350A IL257350A IL25735018A IL257350A IL 257350 A IL257350 A IL 257350A IL 257350 A IL257350 A IL 257350A IL 25735018 A IL25735018 A IL 25735018A IL 257350 A IL257350 A IL 257350A
Authority
IL
Israel
Prior art keywords
pyrazol
pyrimidin
bromo
cancer
amine
Prior art date
Application number
IL257350A
Other languages
Hebrew (he)
Original Assignee
Novartis Ag
Palobiofarma Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2016/054834 external-priority patent/WO2017025918A1/en
Application filed by Novartis Ag, Palobiofarma Sl filed Critical Novartis Ag
Publication of IL257350A publication Critical patent/IL257350A/en

Links

IL257350A 2015-08-11 2018-02-04 5-bromo-2,6-di-(lh-pyrazol-l-yl)pyrimidin-4-amine for use in the treatment of cancer IL257350A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15382425 2015-08-11
US201662335984P 2016-05-13 2016-05-13
PCT/IB2016/054834 WO2017025918A1 (en) 2015-08-11 2016-08-10 5-bromo-2,6-di-(lh-pyrazol-l-yl)pyrimidin-4-amine for use in the treatment of cancer

Publications (1)

Publication Number Publication Date
IL257350A true IL257350A (en) 2018-03-29

Family

ID=65563017

Family Applications (1)

Application Number Title Priority Date Filing Date
IL257350A IL257350A (en) 2015-08-11 2018-02-04 5-bromo-2,6-di-(lh-pyrazol-l-yl)pyrimidin-4-amine for use in the treatment of cancer

Country Status (13)

Country Link
JP (1) JP6964113B2 (en)
KR (1) KR102226100B1 (en)
CL (1) CL2018000349A1 (en)
DK (1) DK3334431T3 (en)
ES (1) ES2761910T3 (en)
HK (1) HK1249409B (en)
HR (1) HRP20192192T1 (en)
HU (1) HUE046646T2 (en)
IL (1) IL257350A (en)
LT (1) LT3334431T (en)
PT (1) PT3334431T (en)
RU (1) RU2745560C2 (en)
ZA (1) ZA201800792B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2365960B1 (en) * 2010-03-31 2012-06-04 Palobiofarma, S.L NEW ANTAGONISTS OF ADENOSINE RECEPTORS.

Also Published As

Publication number Publication date
CL2018000349A1 (en) 2018-09-07
HK1249409B (en) 2020-05-08
KR20200057790A (en) 2020-05-26
JP2019218346A (en) 2019-12-26
RU2018108050A3 (en) 2020-02-17
DK3334431T3 (en) 2020-01-02
RU2745560C2 (en) 2021-03-29
ZA201800792B (en) 2019-06-26
JP6964113B2 (en) 2021-11-10
KR102226100B1 (en) 2021-03-10
HUE046646T2 (en) 2020-03-30
LT3334431T (en) 2019-12-27
ES2761910T3 (en) 2020-05-21
HRP20192192T1 (en) 2020-03-06
PT3334431T (en) 2020-01-06
RU2018108050A (en) 2019-09-13

Similar Documents

Publication Publication Date Title
SG10202111808WA (en) 5-bromo-2,6-di-(1h-pyrazol-1-yl)pyrimidin-4-amine for use in the treatment of cancer
ZA201905902B (en) 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer
HK1256283A1 (en) Dihydroimidazopyrazinone derivatives useful in the treatment of cancer
IL259996A (en) Combinations for the treatment of cancer
IL263802A (en) Cancer treatment combinations
IL251905A0 (en) Apilimod for use in the treatment of renal cancer
IL248767B (en) Trimethoxyphenyl-benzimidazole compound for use in the treatment of cancer
IL251903A0 (en) Apilimod for use in the treatment of colorectal cancer
EP3733184C0 (en) Pyrimidine compounds for use in the treatment of cancer
IL262143A (en) Improvements in cancer treatment
HK1251794A1 (en) Cancer treatment
IL253933A0 (en) Pyrimidine derivatives for use in the treatment of cancer
EP3440052C0 (en) Compounds for use in the treatment of cancer
IL269121A (en) Usl-311 for use in the treatment of cancer
GB201522433D0 (en) Cancer treatment
IL257350A (en) 5-bromo-2,6-di-(lh-pyrazol-l-yl)pyrimidin-4-amine for use in the treatment of cancer
GB2578008B (en) 1-Acetyl-5-Nitro-4-Phenyl-3-Pyrrolin-2-one for use in cancer treatment
PT3580211T (en) 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer
GB2553684B (en) Ethynylxanthines, preparation and use for cancer treatment

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed